SKANEATELES FALLS — Welch Allyn, Inc., a Skaneateles Falls–based manufacturer of medical-diagnostic equipment, on June 3 announced it has acquired certain assets of PediaVision Holdings, LLC, an Orlando–area–based developer of vision technology. Welch Allyn didn’t release any financial terms of the acquisition in its news release. PediaVision, founded in 2007 and headquartered in Lake Mary, […]
SKANEATELES FALLS — Welch Allyn, Inc., a Skaneateles Falls–based manufacturer of medical-diagnostic equipment, on June 3 announced it has acquired certain assets of PediaVision Holdings, LLC, an Orlando–area–based developer of vision technology.
Welch Allyn didn’t release any financial terms of the acquisition in its news release.
PediaVision, founded in 2007 and headquartered in Lake Mary, Fla., invented “Spot,” described as a “new generation of user-friendly vision assessment technology,” according to Welch Allyn.
Spot is a binocular-vision screener with wireless-communication capabilities designed to screen for refractive error, which can be associated with several ophthalmological problems in patients of all ages.
The acquisition allows Welch Allyn to offer its customers a diagnostic device for conducting eye examinations, Stephen Meyer, Welch Allyn’s president and CEO, said in the news release.
It also “complements” the company’s existing vision-screening technology, Meyer said. The company plans a launch of a Welch Allyn-branded version of Spot later this year.
“PediaVision has a solid customer base and the addition of its binocular-vision screener into our existing portfolio of physical-assessment products … will allow us to offer a more robust suite of early-detection solutions for healthcare providers globally,” said Meyer.
PediaVision works to solve the “undiagnosed” vision problems affecting millions of people globally. The PediaVision technology has “quickly captured the attention” of organizations that specialize in vision screening and vision care, David Melnik, CEO of PediaVision, said in the news release.
“We are extremely proud of what we have been able to accomplish and are so thankful to our customers for their passion and support in helping us change the way vision issues are identified. Pediavision has done what its team is best at — delivering innovation that changes the way people solve problems and create value. I truly believe Welch Allyn is the perfect fit to take what Pediavision has built and take it to the next level. Spot couldn’t be in better hands,” Melnik said.
Welch Allyn said it will retain PediaVision’s employees and contractors under a transition-services agreement (TSA) and the workers have been asked to remain with the company in their current capacity through the transition period.
PediaVision’s existing manufacturing partners will continue to develop and source the current product. As the transition continues, “it will be business as usual” for all PediaVision suppliers and customers, according to WelchAllyn.
The news release did not say how many employees PediaVision has currently, but PediaVision’s LinkedIn page lists the company size as 11-50 employees.
Welch Allyn employs more than 2,600 people in 26 different countries, according to its news release.
Contact Reinhardt at ereinhardt@cnybj.com
